Momordica charantia polypeptide product and its application

The discovery and application of "Momordica charantia polypeptide" is of epoch-making significance in the field of diabetes treatment and prevention, and it is a revolution from chemical hypoglycemic to biological hypoglycemic.

Foreign situation

The extraction and purification technology invented by Academician Hanna has been protected by international organizations such as WTO (World Trade Organization) and PCT (World Intellectual Property Organization).

At present, "Momordica charantia polypeptide" has been approved by the government as a medicine in India and sold in all countries except China.

This most representative frontier achievement of biotechnology has caused a great sensation in Europe and America. In the United States, momordica charantia polypeptide has been listed as a plant preparation and passed the examination of FDA.

"Bitter gourd polypeptide" has been protected by invention patents in 95 countries around the world, and products with bitter gourd polypeptide as the main component are gradually being widely used by diabetic patients all over the world.